Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Fredun Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 215.00 -9.55  | -4.25% -20.28% 16.79 89.37
BSE Price: Oct 14, 16:01 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 14, 16:01 215.00 -9.55 -4.25% 224.00 224.55 730 215.00 - 225.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,956 P/B: 2.28 NSE Code:
52-Week Range: R 183.00 - 500.00 Dividend Yield: 0.29% BSE Code: 539730
TTM EPS: R 13.34 Book Value: R 98.31 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Fredun Pharmaceuticals -33.39 -3.09 -39.49 -13.07 104.38 - -
S&P BSE Small Cap -13.15 -0.93 -7.15 -7.45 -1.23 3.77 5.64
S&P BSE Healthcare -12.72 -6.94 -5.50 -15.31 -9.36 -2.37 10.68
Company's return has been calculated on basis of BSE's price.
As on Oct 11, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 62.92 31.85 35.44
Net Profit 154.72 60.96 79.07
EPS 168.74 35.83 63.92
Book Value 51.03 84.04 54.88
Average
Operating Margin 11.01 10.04 9.96
Net Margin 4.57 3.31 2.68
Return on Networth 14.59 20.50 20.92
Return on Investment 23.16 19.07 19.22
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -12.17 71.38 -12.17
Operating Profit -59.99 963.64 -59.99
Net Profit -79.16 137.04 -79.16
EPS -79.16 132.00 -79.16
TTM
Revenue 12.10 63.16 12.10
Operating Profit 16.05 159.72 16.05
Net Profit 19.33 610.55 19.33
EPS 22.10 434.88 22.10
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Fredun Pharmaceuticals 89.37 109.19 5.32 4.87 14.59 2.28 16.79
Astrazeneca Pharma India 5,444.13 771.42 69.56 8.84 20.03 17.00 78.26
Eris Lifesciences 5,931.23 1,005.70 303.64 29.29 28.96 4.81 19.54
Fund Houses invested in the stock
Fund Dec-98 Dec-98 Dec-98 Sep-98 Jun-98
Tata Mutual Fund 1.003 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Fredun Pharmaceuticals Ltd.

Address: 26 , Manoj Industrial Premises, G . D . Ambekar Marg, Wadala, Mumbai, Maharashtra - 400031 | Phone: +91-22-40318111 | Fax: +91-22-40318133

Email: [email protected]

Website: www.fredungroup.com

Registrar & Transfer Agent: Purva Shareregistry (India) Pvt Ltd

Address: Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg, Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E]

Essential checks
Altman Z-Score
2.95
Piotroski F-Score
6
Modified C-Score
2
3-Years Price to Earnings
16.83
3-Years Price to Book
2.28
Earnings Yield
EBIT / Enterprise value
11.32%
PEG
Price / Earnings to growth ratio
0.28
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,170.35 -1.31%
Caplin Point Laboratories R402.05 +0.59%
Eris Lifesciences R432.25 +1.02%
FDC R160.15 -1.84%
JB Chemicals & Pharma R359.50 -0.26%
Laurus Labs R319.90 -2.04%
Strides Pharma Science R338.50 +4.35%
Sun Pharma Adv. Research R118.85 +2.59%
Suven Life Sciences R258.20 +0.12%
Wockhardt R253.70 +1.20%
As on Oct 14, 15:54